Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

US President Donald Trump (L) looks on as Health and Human Services Secretary Alex Azar speaks during a news conference on the COVID-19 outbreak at the White House on February 26, 2020. (Photo: Andrew Caballero-Reynolds/AFP via Getty Images)

'An Outrage': HHS Chief Azar Refuses to Vow Coronavirus Vaccine Will Be Affordable for All, Not Just the Rich

"This is what happens when you put a Big Pharma CEO who doubled the price of insulin in charge of regulating Big Pharma."

Jake Johnson

Members of Congress and advocacy groups are voicing outrage after Health and Human Services Secretary Alex Azar—a former pharmaceutical executive—repeatedly refused during House testimony Wednesday to guarantee that any coronavirus vaccine or treatment developed with taxpayer money will be affordable for all in the U.S., not just the rich.

"Under the Trump doctrine, if you are wealthy you can buy a vaccine and not succumb to the sickness," Sen. Bernie Sanders (I-Vt.), a Democratic presidential candidate, said in a statement. "If you are poor or working class, you may have to get sick or even die. That is an outrage. That is unacceptable. We need a vaccine that is available to all."

"He's giving Big Pharma a blank check to monopolize them instead."
—Rep. Jan Schakowsky

During testimony before the House Energy and Commerce Committee Wednesday, Azar was pressed multiple times to vow that vaccines and treatments for the coronavirus will be priced fairly and made affordable for all U.S. households.

"We would want to ensure that we'd work to make it affordable," Azar told Rep. Jan Schakowsky (D-Ill.), "but we can't control that price because we need the private sector to invest."

Schakowsky tweeted following the hearing that she gave Azar "THREE chances to assure us that any coronavirus vaccines or treatments developed with U.S. taxpayer dollars will be affordable and accessible to everyone and he flat out refused to do so."

"He's giving Big Pharma a blank check to monopolize them instead," added Schakowsky.

Progressive advocacy group Social Security Works said late Wednesday that "this is what happens when you put a Big Pharma CEO who doubled the price of insulin in charge of regulating Big Pharma," referring to Azar's tenure at Eli Lilly.

"Pharma and their friends in the Trump admin don't care how many people die," the group wrote, "as long as they get to make a profit."

Hours after Azar's testimony, President Donald Trump announced in a press conference with Centers for Disease Control and Prevention officials that Vice President Mike Pence will lead the administration's effort to combat the coronavirus outbreak. Azar was reportedly "blindsided" by the president's decision to put Pence in charge.

Trump continued to downplay the threat the virus poses in the U.S., claiming "we've had tremendous success, tremendous success beyond what many people would've thought," as his administration faces criticism for its slow and woefully inadequate response.

"Because of all we've done, the risk to the American people remains very low," Trump claimed.

Shortly following Trump's press conference, CDC officials announced that a person in California tested positive for the coronavirus.

The individual "was not exposed to anyone known to be infected with the coronavirus," the New York Times reported, "and had not traveled to countries in which the virus is circulating."

"It brings the number of cases in the country to 60," the Times noted, "including the 45 cases among Americans who were repatriated from Wuhan, China—the epicenter of the outbreak—and the Diamond Princess cruise ship, which was overwhelmed by the virus after it docked in Japan."


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

... We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.

Biden Continues Drilling Boom on Public Lands Despite Campaign Pledge, Analysis Shows

"The reality is that in the battle between the oil industry and Biden, the industry is winning."

Julia Conley ·


Rights Groups Decry 'Farcical and Corrupt' Verdict as Myanmar's Suu Kyi Sentenced to Four Years in Prison

"There are many detainees without the profile of Aung San Suu Kyi who currently face the terrifying prospect of years behind bars simply for peacefully exercising their human rights."

Jake Johnson ·


Campaigners Warn of 'Wave After Wave of Variants' as Long as Vaccine Apartheid Remains

"Omicron is with us because we have failed to vaccinate the world. This should be a wake-up call."

Jake Johnson ·


'Utterly Obscene': Just 8 Pfizer and Moderna Investors Became $10 Billion Richer After Omicron Emerged

"Pharma execs and shareholders are making a killing from a crisis they helped to create," said one justice campaigner.

Jon Queally ·


Ilhan Omar Calls Kevin McCarthy 'A Liar and a Coward' for Refusing to Condemn Boebert's Islamophobia

"This is who they are," said the Minnesota Democrat. "And we have to be able to stand up to them. And we have to push them to reckon with the fact their party right now is normalizing anti-Muslim bigotry."

Jon Queally ·

Support our work.

We are independent, non-profit, advertising-free and 100% reader supported.

Subscribe to our newsletter.

Quality journalism. Progressive values.
Direct to your inbox.

Subscribe to our Newsletter.


Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit | Privacy Policy
Common Dreams Logo